Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07204626
Starting soon Observational

Medical Anthropology and Migrants in Precarious Situations, Cared for in Intensive and Post-intensive Care Units

NCT07204626 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-10-15
Last updated
2025-10-02

Condition(s) studied

AnthropologyImmigrantIntensive Care (ICU)Precariousness

Study summary

Analyze the experience (perception, interpretation and incorporation - embodiment) that migrant people with low socio-economic status/precarity have of their own health conditions for which they have come to be hospitalized in the Intensive Care Unit (ICU) and Post-Resuscitation Rehabilitation Care (PRRC).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: For patients: Male and female migrants (born outside of France and its territories, regardless of date of arrival, length of residence, or acquired nationality) Aged 18 years or older Living in or transiting through France With or without residence permits or legal documentation Hospitalized in ICUs and receiving care in post-ICU rehabilitation units (SRPR) Providing consent to participate in the study Having good proficiency in French, Spanish, or Italian, or, if not, benefiting from professional interpretation (ISM) or cultural mediation ensuring effective communication Having a psychological and neurological state compatible with providing informed consent and taking part in an interview For healthcare professionals and associative actors: Being a healthcare, social work, or associative professional Involved in the medical, psycho-social, and/or legal support and care of migrant patients admitted to ICUs and SRPR Providing consent to participate in the study Exclusion Criteria: For patients: Being born in France Being a minor (\<18 years old) Being under guardianship or curatorship Having a neurological state incompatible with providing informed consent and taking part in an interview For healthcare professionals and associative actors: Not being involved in the care of migrant patients admitted to ICUs and SRPR

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre Hospitalier de Saint-Denis Saint-Denis France

More Centre Hospitalier de Saint-Denis trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07204626 on ClinicalTrials.gov ↗ ← All trials in France